Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients

Thrombosis Research

Volumn 131, Issue 1, 2013, Pages 17-23

  Gussoni, Gualberto ^a   Foglia, Emanuela ^b   Frasson, Stefania ^a   Casartelli, Luca ^b   Campanini, Mauro ^c   Bonfanti, Marzia ^b   Colombo, Fabrizio ^d   Porazzi, Emanuele ^b   Ageno, Walter ^e   Vescovo, Giorgio ^f   Mazzone, Antonino ^g  

^a FADOI Foundation   (Italy)

^b Center for Research on Health Economics   (Italy)

^c Hospital Maggiore della Carità   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f Department of Internal Medicine   (Italy)

^g Civil Hospital   (Italy)

Author keywords

Activity Based Costing; Antithrombotic prophylaxis; Economic burden; Internal Medicine; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; BLOOD EXAMINATION; CONTROLLED STUDY; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; ITALY; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; COST SAVINGS; COST-BENEFIT ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; DRUG COSTS; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HOSPITAL COSTS; HOSPITAL UNITS; HUMANS; INPATIENTS; INTERNAL MEDICINE; ITALY; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, ECONOMIC; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE HEALTH SERVICES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84871670555     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.10.008     Document Type: Article

References (44)

1. S.R. Kahn, W. Lim, A.S. Dunn, M. Cushman, F. Dentali, and E.A. Akl Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines Chest 141 2012 e195S e226S
2. A.T. Cohen, G. Agnelli, F.A. Anderson, J.I. Arcelus, D. Bergqvist, and J.G. Brecht Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality Thromb Haemost 98 2007 756 764 (Pubitemid 47555066)
3. M.M. Samama, A.T. Cohen, J.-Y. Damon, L. Desjardins, A. Eldor, and C. Janbon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 1999 793 800 (Pubitemid 29420474)
4. A. Leizorovicz, A.T. Cohen, A.G. Turpie, C.G. Olsson, P.T. Vaitkus, and S.Z. Goldhaber Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879 (Pubitemid 39096017)
5. A.T. Cohen, B.L. Davidson, A.S. Gallus, M.R. Lassen, M.H. Prins, and W. Tomkowski Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial Br Med J 332 2006 325 329
6. A. Amin, S. Stemkowski, J. Lin, and G. Yang Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost 5 2007 1610 1616 (Pubitemid 47091400)
7. G. Gussoni, M. Campanini, M. Silingardi, G. Scannapieco, A. Mazzone, and G. Magni In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study Thromb Haemost 1001 2009 893 901
8. V.F. Tapson, H. Decousus, M. Pini, B.H. Chong, J.B. Froehlich, and M. Monreal Venous thromboembolism prophylaxis in acutely hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism Chest 132 2007 936 945
9. A.C. Spyropoulos Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients Chest 128 2005 958 969 (Pubitemid 41140532)
10. M. Campanini, G. Gussoni, M. Silingardi, G. Scannapieco, C. Buniolo, and A. Valerio Risk factors for venous thromboembolism and prophylaxis in medical inpatients: data from the FADOI GEMINI study Ital J Med 4 2010 24 31
11. A.J. Kakkar, C. Cimminiello, S.Z. Goldhaber, R. Parakh, C. Wang, and J.-F. Bergmann Low-molecular-weight-heparin and mortality in acutely ill medical patients N Engl J Med 365 2011 2463 2472
12. P.P. Dobesh Economic burden of venous thromboembolism in hospitalized patients Pharmacotherapy 29 2009 943 953
13. D.A. Ollendorf, M. Vera-Llonch, and G. Oster Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients Am J Health Syst Pharm 59 2002 1750 1754 (Pubitemid 35033913)
14. A. Ruppert, T. Steinle, and M. Lees Economic burden of venous thromboembolism: a systematic review J Med Econ 14 2011 65 74
15. H. Bounameaux, A. Perrier, and M. Righini Diagnosis of venous thromboembolism: an update Vasc Med 15 2010 399 406
16. A. Perone, H. Bounameux, and A. Perrier Comparison of four strategies for diagnosing deep vein thrombosis: a cost-effectiveness analysis Am J Med 110 2001 33 40 (Pubitemid 32056325)
17. R.A. Douma, I.C.M. Mos, P.M.G. Erkens, T.A.C. Nizet, M.F. Durlan, and M.M. Hovens Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism Ann Intern Med 154 2011 709 718
18. A.N. Amin, J. Lin, B.H. Johnson, and K.L. Schulman Clinical and economic outcomes with appropriate or partial prophylaxis Thromb Res 125 2010 513 517
19. G. de Lissovoy, and P. Subedi Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective Am J Manag Care 8 2002 1082 1088 (Pubitemid 36040583)
20. M.J. Nuijten, P. Berto, J. Kosa, C. Cimminiello, and A. Spreafico Cost-effectiveness of enoxaparin as thromboprophylaxis in acutely ill medical patients from the Italian NHS perspective Recenti Prog Med 93 2002 80 91 (Pubitemid 34150358)
21. Y.C.L. Chan Improving hospital cost accounting with activity based costing Health Care Manage Rev 18 1 1993 71 77
22. S. Udpa Activity Based Costing for Hospital Health Care Manage Rev 21 3 1996 83 96
23. L.J. Mc Garry, D. Thompson, M.C. Weinstein, and S.Z. Goldhaber Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients Am J Manag Care 10 2004 632 642 (Pubitemid 39287373)
24. R. Cooper, and R.S. Kaplan Measure costs right: make the right decisions Harv Bus Rev 1988 96 103
25. P. Miolo, D. Vitali, and S. Nuti Sperimentazione dell'activity based management nella sanità pubblica 2004 Franco Angeli Ed.
26. A. Lamy, X. Wang, R. Kent, K.M. Smith, and A. Gafni Economic evaluation of the MEDENOX trial: a Canadian perspective - medical patients with enoxaparin Can Respir J 9 2002 169 177 (Pubitemid 34863634)
27. F.A. Spencer, D. Lessard, C. Emery, G. Reed, and R.J. Goldberg Venous thromboembolism in the outpatient setting Arch Intern Med 167 2007 1471 1475 (Pubitemid 47124177)
28. J.A. Heit, D.N. Mohr, M.D. Silverstein, T.M. Petterson, M. O'Fallon, and I.J. Melton III Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study Arch Intern Med 160 2000 761 768 (Pubitemid 30165236)
29. M. Cushman, A.W. Tsai, R.H. White, S.R. Heckbert, W.D. Rosamond, and P. Enright Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology Am J Med 117 2004 19 25 (Pubitemid 38801482)
30. D.A. MacDougall, A.L. Feliu, S.J. Boccuzzi, and J. Lin Economic burden of deep vein thrombosis, pulmonary embolism, and post-thrombotic syndrome Am J Health Syst Pharm 63 2006 S5 S15 (Pubitemid 44672124)
31. A. Spyropoulos Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations J Manag Care Pharm 13 2007 475 486 (Pubitemid 350193368)
32. V. Pengo, A.W. Lensing, M.H. Prins, A. Marchiori, B.L. Davidson, and F. Tiozzo Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism N Engl J Med 350 2004 2257 2264
33. M.F. Bullano, V. Willey, O. Hauch, G. Wygant, A.C. Spyropoulos, and L. Hoffman Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization J Manag Care Pharm 11 2005 663 673
34. D. Bergqvist, S. Jendteg, L. Johansen, U. Persson, and K. Odegaard Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden Ann Intern Med 126 1997 454 457 (Pubitemid 27114474)
35. R.D. Hull, S.M. Schellong, V.F. Tapson, M. Monreal, M.M. Samama, and P. Nicol Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial Ann Intern Med 153 2010 8 18
36. S.Z. Goldhaber, A. Leizorovicz, A.K. Kakkar, S.K. Haas, G. Merli, and R.M. Knabb Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients N Engl J Med 365 2011 2167 2177
37. D.J. Tillman, S.L. Charland, and D.M. Witt Effectiveness and economic impact associated with a program of outpatient management of acute deep vein thrombosis in a group model health maintenance organization Arch Intern Med 160 2000 2926 2932 (Pubitemid 32009049)
38. K.K. Knight, J. Wong, O. Hauch, G. Wigant, D. Aguilar, and J.J. Ofman Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients Value Health 8 2005 191 200 (Pubitemid 41023478)
39. M. Levine, M. Gent, J. Hirsh, J. Leclerc, D. Anderson, and J. Weitz A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis N Engl J Med 11 1996 677 681 (Pubitemid 26079800)
40. M.M.W. Koopman, P. Prandoni, F. Piovella, P.A. Ockelford, D.P. Brandjes, and J. van der Meer Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home N Engl J Med 11 1996 682 687
41. D. Aujesky, P.-M. Roy, F. Verschuren, M. Righini, J. Osterwalder, and M. Egloff Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomized, non-inferiority trial Lancet 378 2011 41 48
42. P.K. Schadlich, M. Kentsch, M. Weber, W. Kammerer, J.G. Brecht, and V. Nadipelly Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients. Modelling study from the hospital perspective in Germany Pharmacoeconomics 24 2006 571 591 (Pubitemid 43886268)
43. S.R. Kahn, A. Panju, W. Geerts, G.F. Pineo, L. Desjardins, and A.G. Turpie Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada Thromb Res 119 2007 145 155 (Pubitemid 44810862)
44. J.F. Bergmann, A.T. Cohen, V.F. Tapson, S.Z. Goldhaber, A.K. Kakkar, and B. Deslandes Venous thromboembolism risk and prophylaxis in hospitalized medically ill patients. The ENDORSE Global Survey Thromb Haemost 103 2010 736 748